← Back to patent-cliff list
Huperizine-A (Biscayne Pharmaceuticals)
Tier C — Watch / tradeHuperizine-A (Biscayne Pharmaceuticals)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NMDAR, AChE
Brand：Cerebra
Indications (approved)：Seizure, 癫痫的复杂部分性发作
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Huperizine-A (Biscayne Pharmaceuticals)?
Approved indications include: Seizure, 癫痫的复杂部分性发作.
When does the Huperizine-A (Biscayne Pharmaceuticals) patent expire?
No public expiry year is available for Huperizine-A (Biscayne Pharmaceuticals) yet; this page updates once verified.
How do I get a quote for Huperizine-A (Biscayne Pharmaceuticals) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-08